{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:39:08Z","timestamp":1787855948729,"version":"build-2784847793"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colon cancer (CC), characterized by high incidence and mortality, ranks among the most prevalent digestive malignancies, and reliable molecular tools to predict prognosis and immunotherapy response are needed. Disulfidptosis is a recently identified form of programmed cell death induced by disulfide stress and represents a potential therapeutic target for CC. However, the prognostic and immunological implications of disulfidptosis-related genes (DRGs) in CC remain underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>RNA sequencing and clinical data from TCGA and GEO databases (GSE39582, GSE17536) were analyzed. A prognostic model including five DRGs (RAB7A, SLC7A11, INF2, FLNA, OXSM) was established using WGCNA, univariate Cox, and LASSO-Cox regression. Patients were stratified into high- and low-risk groups based on risk scores. The model was cross-validated by Kaplan-Meier, time-dependent ROC, nomogra, and multivariable Cox analyses. Immune infiltration (ssGSEA), tumor-mutation burden, miRNA-DRG networks, and drug-sensitivity correlations (CCLE\/GDSC\/CellMiner) were assessed. Protein expression of RAB7A and OXSM was further examined in tissue microarrays (TMAs) of 97 CCs with matched normal mucosae using immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A 5-DRGs prognostic model was established which serves as an independent signal of overall survival and immunotherapy efficacy in CC. Low-risk group patients exhibited an immune-favorable microenvironment and were more abundant with activated CD56 bright NK, \u03b3\u03b4-T, and Th17 cells, higher tumor mutational burden (TMB), and elevated CTLA-4 expression, which were likely associated with improved response to immune checkpoint inhibitors (ICIs). As a risk factor, RAB7A relating to poor prognosis was identified in our study, and was a potential target for therapeutic agents such as PLX4720 and PD-0325901, while OXSM was the opposite. Therefore, this model serves as a translatable framework for the precision management of CC, enabling rational risk stratification and facilitating personalized treatment decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The 5-DRGs prognostic model can be used to assess the prognosis of patients with CC, and reflect the characteristics of their immune microenvironment. With RAB7A and OXSM as key determinants, this model provides a clinically applicable framework for risk stratification and personalized treatment guidance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmolb.2026.1756041","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:45:44Z","timestamp":1769582744000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Disulfidptosis-related genes signature predicts prognosis and immune microenvironment in colon cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Wei","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of General Surgery, The First Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxia","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau","place":["Taipa, Macao SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Xijing Hospital, Air Force Medical University","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyou","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Medical Center, Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1056\/NEJMoa2402141","article-title":"Nivolumab plus ipilimumab in microsatellite-instability-high metastatic colorectal cancer","volume":"391","author":"Andre","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The gene ontology consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"B5","unstructured":"timeROC: time-dependent ROC curve and AUC for censored survival data\n          \n          \n            \n              Blanche\n              P.\n            \n          \n          \n          2019"},{"key":"B6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41586-022-05593-1","article-title":"\u03b3\u03b4 T cells are effectors of immunotherapy in cancers with HLA class I defects","volume":"613","author":"de Vries","year":"2023","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41419-024-06431-0","article-title":"Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer","volume":"15","author":"Ding","year":"2024","journal-title":"Cell Death Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1093\/bib\/bbz142","article-title":"RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data","volume":"21","author":"Dong","year":"2020","journal-title":"Brief. Bioinform."},{"key":"B10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","article-title":"Targeting the MAPK pathway in KRAS-driven tumors","volume":"37","author":"Drosten","year":"2020","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13048-023-01156-8","article-title":"Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM)","volume":"16","author":"Duan","year":"2023","journal-title":"J. Ovarian Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-020-01151-3","article-title":"Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma","volume":"19","author":"Fan","year":"2020","journal-title":"Mol. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cells5030034","article-title":"Multiple roles of the small GTPase Rab7","volume":"5","author":"Guerra","year":"2016","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/cancers11081096","article-title":"Role of the RAB7 protein in tumor progression and cisplatin chemoresistance","volume":"11","author":"Guerra","year":"2019","journal-title":"Cancers"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B17","doi-asserted-by":"publisher","first-page":"106221","DOI":"10.1016\/j.intimp.2020.106221","article-title":"CTLA-4: from mechanism to autoimmune therapy","volume":"80","author":"Hosseini","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12403","DOI":"10.1038\/s41598-023-39563-y","article-title":"A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in Colon adenocarcinoma","volume":"13","author":"Hu","year":"2023","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2023.2180196","article-title":"WTAP regulates autophagy in Colon cancer cells by inhibiting FLNA through N6-methyladenosine","volume":"17","author":"Huang","year":"2023","journal-title":"Cell Adhes. Migr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1006748","DOI":"10.1371\/journal.pgen.1006748","article-title":"Dysregulation of INF2-mediated mitochondrial fission in SPOP-Mutated prostate cancer","volume":"13","author":"Jin","year":"2017","journal-title":"PLoS Genet."},{"key":"B21","unstructured":"Rms: regression modeling strategies\n          \n          \n            \n              Jr\n              F. E. H.\n            \n          \n          \n          2024"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7632","DOI":"10.1038\/s41598-024-58004-y","article-title":"CircGPC3 promotes hepatocellular carcinoma progression and metastasis by sponging miR-578 and regulating RAB7A\/PSME3 expression","volume":"14","author":"Ju","year":"2024","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/nar\/gkx1141","article-title":"DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions","volume":"46","author":"Karagkouni","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinforma."},{"key":"B27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1200\/JCO.21.01015","article-title":"First-line nivolumab plus low-dose ipilimumab for microsatellite instability-High\/Mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study","volume":"40","author":"Lenz","year":"2022","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"16238","DOI":"10.1002\/jcp.28287","article-title":"Suppression of tafazzin promotes thyroid cancer apoptosis via activating the JNK signaling pathway and enhancing INF2-mediated mitochondrial fission","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1101\/gad.348226.120","article-title":"Genetic and biological hallmarks of colorectal cancer","volume":"35","author":"Li","year":"2021","journal-title":"Genes Dev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"13344","DOI":"10.1038\/s41598-023-40381-5","article-title":"A novel disulfidptosis and glycolysis related risk score signature for prediction of prognosis and ICI therapeutic responsiveness in colorectal cancer","volume":"13","author":"Li","year":"","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"13995","DOI":"10.1007\/s00432-023-05211-1","article-title":"Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in colorectal cancer","volume":"149","author":"Li","year":"","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","article-title":"Pan-cancer genetic analysis of disulfidptosis-related gene set","author":"Liu","year":"2023","journal-title":"Cancer Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"17492","DOI":"10.1038\/s41598-022-22355-1","article-title":"High RAS-Related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"","journal-title":"Nat. Cell Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"106862","DOI":"10.1016\/j.compbiomed.2023.106862","article-title":"Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma","volume":"158","author":"Liu","year":"","journal-title":"Comput. Biol. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-025-03375-x","article-title":"Natural killer cells: the immune frontline against circulating tumor cells","volume":"44","author":"Masmoudi","year":"2025","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1021\/acs.nanolett.7b03358","article-title":"The role of vimentin in regulating cell invasive migration in dense cultures of breast carcinoma cells","volume":"17","author":"Messica","year":"2017","journal-title":"Nano Lett."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e190778","DOI":"10.1172\/JCI190778","article-title":"Tissue-specific anti-tumor NK cell subsets identified in colorectal cancer liver metastases express candidate therapeutic targets","volume":"135","author":"Mikulak","year":"2025","journal-title":"J. Clin. Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"8910","DOI":"10.3390\/ijms22168910","article-title":"Strategies to improve the antitumor effect of \u03b3\u03b4 T cell immunotherapy for clinical application","volume":"22","author":"Miyashita","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"B42","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000491019","article-title":"The number of natural killer cells in the largest diameter lymph nodes is associated with the number of retrieved lymph nodes and lymph node size, and is an independent prognostic factor in patients with stage II Colon cancer","volume":"95","author":"Okada","year":"2018","journal-title":"Oncology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","article-title":"Plasmacytoid dendritic cells: development, regulation, and function","volume":"50","author":"Reizis","year":"2019","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-Sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"915837","DOI":"10.3389\/fimmu.2022.915837","article-title":"Gamma Delta T-Cell based cancer immunotherapy: past-present-future","volume":"13","author":"Saura-Esteller","year":"2022","journal-title":"Front. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e70006","DOI":"10.1002\/biof.70006","article-title":"Investigating the impact of Ras-related protein RAB7A on Colon adenocarcinoma behavior and its clinical significance","volume":"51","author":"Shan","year":"2025","journal-title":"BioFactors Oxf. Engl."},{"key":"B48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/1471-2164-10-277","article-title":"CellMiner: a relational database and query tool for the NCI-60 cancer cell lines","volume":"10","author":"Shankavaram","year":"2009","journal-title":"BMC Genomics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for cox\u2019s proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J. Stat. Softw."},{"key":"B51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41551-022-00973-4","article-title":"Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles","volume":"7","author":"Son","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"B52","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","article-title":"The gene ontology resource: 20 years and still GOing strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B53","article-title":"A Package for Survival Analysis in R. R package version 3.8-3","author":"Therneau","year":"2024"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1172\/JCI90387","article-title":"CD56bright NK cells exhibit potent antitumor responses following IL-15 priming","volume":"127","author":"Wagner","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B55","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innov. Camb. Mass"},{"key":"B56","doi-asserted-by":"publisher","first-page":"20135","DOI":"10.1038\/s41598-023-47472-3","article-title":"A disulfidptosis-related lncRNA index predicting prognosis and the tumor microenvironment in colorectal cancer","volume":"13","author":"Xiao","year":"2023","journal-title":"Sci. Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1333834","DOI":"10.3389\/fmolb.2025.1333834","article-title":"Risk factors of colorectal cancer in middle-aged and elder adults in China: findings from the China health and retirement longitudinal study","volume":"12","author":"Zhang","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","article-title":"Disulfidptosis: a new target for metabolic cancer therapy","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"B60","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/ijms23020852","article-title":"Novel diagnostic biomarkers in colorectal cancer","volume":"23","author":"Zygulska","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1756041\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:45:46Z","timestamp":1769582746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1756041\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":59,"alternative-id":["10.3389\/fmolb.2026.1756041"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1756041","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"article-number":"1756041"}}